Entropy Technologies LP Takes Position in Bath & Body Works, Inc. (NYSE:BBWI)

Entropy Technologies LP purchased a new stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 32,846 shares of the company's stock, valued at approximately $1,273,000.

Several other institutional investors and hedge funds also recently modified their holdings of BBWI. Golden State Wealth Management LLC acquired a new position in shares of Bath & Body Works in the fourth quarter valued at approximately $26,000. UMB Bank n.a. raised its position in shares of Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after buying an additional 335 shares during the last quarter. True Wealth Design LLC raised its position in shares of Bath & Body Works by 5,270.0% in the third quarter. True Wealth Design LLC now owns 1,074 shares of the company's stock valued at $34,000 after buying an additional 1,054 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its position in shares of Bath & Body Works by 300.0% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company's stock valued at $38,000 after buying an additional 900 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new position in shares of Bath & Body Works in the third quarter valued at approximately $39,000. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI traded up $0.07 during midday trading on Friday, hitting $36.50. 1,835,171 shares of the company's stock traded hands, compared to its average volume of 3,008,922. The company has a market cap of $7.91 billion, a PE ratio of 8.90, a P/E/G ratio of 0.90 and a beta of 1.83. The firm's fifty day moving average price is $37.63 and its two-hundred day moving average price is $33.70. Bath & Body Works, Inc. has a twelve month low of $26.20 and a twelve month high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping analysts' consensus estimates of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.58 billion. During the same quarter in the previous year, the business posted $0.48 EPS. The firm's revenue was up 3.1% compared to the same quarter last year. As a group, equities research analysts anticipate that Bath & Body Works, Inc. will post 3.26 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 21st will be issued a $0.20 dividend. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.19%. Bath & Body Works's dividend payout ratio is currently 19.51%.

Wall Street Analysts Forecast Growth

BBWI has been the subject of several research analyst reports. Barclays upped their price target on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an "underweight" rating in a research report on Tuesday, November 26th. Telsey Advisory Group reaffirmed an "outperform" rating and set a $42.00 price target on shares of Bath & Body Works in a research report on Monday, November 25th. Argus reaffirmed a "hold" rating on shares of Bath & Body Works in a research report on Friday, January 10th. JPMorgan Chase & Co. upped their price target on shares of Bath & Body Works from $39.00 to $41.00 and gave the stock a "neutral" rating in a research report on Friday, January 24th. Finally, Morgan Stanley dropped their price target on shares of Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating for the company in a research report on Thursday, November 21st. One research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $43.19.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.